Ordering Information — Limited to 10 units per online order. For any larger orders, contact us through our link at the bottom of the page.
Strain CWL-029 is cultured in HL cells. Microbix has a proprietary production process allowing for optimal yield of C. pneumoniae elementary bodies. The final preparation is resuspended in SPG buffer and gamma irradiated. View the Sample Product Information Sheet.
Chlamydophila pneumoniae is an emerging intracellular bacterial pathogen that causes both upper and lower respiratory tract infections. According to reliable reports, C. pneumoniae accounts for 10-25% of community-acquired pneumonia cases. As studies suggest, this bacterium may play a role in the pathogenesis of atherosclerosis while other studies are exploring possible links with Alzheimer’s disease, arthritis, and asthma.
Inactivation & Safety — Each lot of Chlamydiae antigen inactivated using gamma radiation and this inactivation verified using a sensitive tissue culture based infectivity assay.
Applications — ELISA, Western Blot.
Each antigen lot is tested for potency using ELISA, and compared to a reference antigen. This ensures the amount of viral protein in each batch is consistent. The total protein concentration reported includes both viral and non-viral proteins, with the ratio dependent on the purity of the antigen. View our Quality Policy and ISO Certification.